# Bolus Versus Prolonged Infusion of Meropenem in Newborn With Late Onset Sepsis

> **NCT02503761** · PHASE3 · COMPLETED · sponsor: **Mansoura University** · enrollment: 100 (actual)

## Conditions studied

- Late Onset Neonatal Sepsis

## Interventions

- **DRUG:** Meropenem.

## Key facts

- **NCT ID:** NCT02503761
- **Lead sponsor:** Mansoura University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-08
- **Primary completion:** 2015-06
- **Final completion:** 2015-06
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2015-07-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02503761

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02503761, "Bolus Versus Prolonged Infusion of Meropenem in Newborn With Late Onset Sepsis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02503761. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*